You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Twitter Demographics
Mendeley readers
Attention Score in Context
| Title |
The end of a dogma: the safety of doxycycline use in young children for malaria treatment
|
|---|---|
| Published in |
Malaria Journal, April 2017
|
| DOI | 10.1186/s12936-017-1797-9 |
| Pubmed ID | |
| Authors |
Tiphaine Gaillard, Sébastien Briolant, Marylin Madamet, Bruno Pradines |
| Abstract |
Anti-malarial drug resistance to chloroquine and sulfadoxine-pyrimethamine has spread from Southeast Asia to Africa. Furthermore, the recent emergence of resistance to artemisinin-based combination therapy (ACT) in Southeast Asia highlights the need to identify new anti-malarial drugs. Doxycycline is recommended for malaria chemoprophylaxis for travel in endemic areas, or in combination with the use of quinine for malaria treatment when ACT is unavailable or when the treatment of severe malaria with artesunate fails. However, doxycycline is not used in young children under 8 years of age due to its contraindication due to the risk of yellow tooth discolouration and dental enamel hypoplasia. Doxycycline was developed after tetracycline and was labelled with the same side-effects as the earlier tetracyclines. However, recent studies report little or no effects of doxycycline on tooth staining or dental enamel hypoplasia in children under 8 years of age. In the United States, the Centers for Disease Control and Prevention have recommended the use of doxycycline for the treatment of acute and chronic Q fever and tick-borne rickettsial diseases in young children. It is time to rehabilitate doxycycline and to recommend it for malaria treatment in children under 8 years of age. |
Twitter Demographics
The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Congo, The Democratic Republic of the | 1 | 9% |
| Serbia | 1 | 9% |
| United States | 1 | 9% |
| Canada | 1 | 9% |
| Ireland | 1 | 9% |
| United Kingdom | 1 | 9% |
| Belgium | 1 | 9% |
| Unknown | 4 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 45% |
| Practitioners (doctors, other healthcare professionals) | 4 | 36% |
| Science communicators (journalists, bloggers, editors) | 2 | 18% |
Mendeley readers
The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mozambique | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 141 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 15% |
| Student > Master | 17 | 12% |
| Other | 15 | 10% |
| Student > Bachelor | 14 | 10% |
| Student > Ph. D. Student | 12 | 8% |
| Other | 30 | 21% |
| Unknown | 34 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 38% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 9% |
| Biochemistry, Genetics and Molecular Biology | 8 | 6% |
| Immunology and Microbiology | 6 | 4% |
| Agricultural and Biological Sciences | 6 | 4% |
| Other | 14 | 10% |
| Unknown | 42 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2022.
All research outputs
#2,588,303
of 24,400,706 outputs
Outputs from Malaria Journal
#560
of 5,827 outputs
Outputs of similar age
#48,062
of 313,923 outputs
Outputs of similar age from Malaria Journal
#19
of 136 outputs
Altmetric has tracked 24,400,706 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,827 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 136 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.